Tech Company Financing Transactions
Code Biotherapeutics Funding Round
4BIO Capital, UPMC Health Plan and CureDuchenne Ventures joined a $10 million Seed capital raise for Code Biotherapeutics. The financing round was announced on 4/21/2021.
Transaction Overview
4BIO Capital (Lead Investor) (Dima Kuzmin)
UPMC Health Plan (Lead Investor) (Robert Lin)
CureDuchenne Ventures (Debra Miller)
Company Information
Hatfield, PA 19440
USA
Management Team
Browse more venture capital transactions:
Prev: 4/21/2021: Cape Privacy venture capital transaction
Next: 4/21/2021: Injective Protocol venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs